Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis

Cancer Research

Volumn 58, Issue 3, 1998, Pages 526-534

  Von Reyher, Ulrike ^a   Sträter, Jörn ^a   Kittstein, Walter ^b   Gschwendt, Michael ^b   Krammer, Peter H ^b   Möller, Peter ^a  

^a UNIVERSITY OF ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CYCLOHEXIMIDE; DACTINOMYCIN; DNA FRAGMENT; FAS ANTIGEN; GAMMA INTERFERON; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C INHIBITOR; STAUROSPORINE;

APOPTOSIS; ARTICLE; CARCINOMA CELL; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; INTESTINE CRYPT; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TRANSPORT;

EID: 2642634799     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S-I., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66: 233-243, 1991.
2. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richard, S., Dhein, J., Trauth, B. C., Ponsting, W., and Krammer, P. H. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem., 267: 10709-10715, 1992.
3. Dhein, J., Daniel, P. T., Trauth, B. C., Oehm, A., Möller, P., and Krammer, P. H. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol., 149: 3166-3173, 1992.
4. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., and Nagata, S. Human Fas ligand: gene structure, chromosomal location and species specifity. Int. Immunol., 10: 1567-1574, 1994.
5. Smith, C. A., Farrah, T., and Goodwin, R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell, 76: 959-962, 1994.
6. Dhein, J., Walczak, H., Bäumle, C., Debatin, K-M., and Krammer, P. H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (Lond.), 373: 438-440, 1995.
7. Tanaka, M., Suda, T., Takahashi, T., and Nagata, S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J., 14: 1129-1135, 1995.
8. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubl, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., and Green, D. R. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.), 373: 441-444, 1995.
9. Ju, S-T., Panka, D. J., Cui, H., Ettinger, R., El-Kahtib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (Lond.), 373: 444-448, 1995.
10. Mariani, S. M., Matiba, B., Bäumler, C., and Krammer, P. H. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol., 25: 2303-2307, 1995.
11. Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K-M., Krammer, P. H., and Möller, P. Constitutive und induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest., 69: 415-429, 1993.
12. Möller, P., Koretz, K., Leithäuser, F., Brüderlein, S., Henne, C., Quentmeier, A., and Krammer, P. H. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer., 57: 371-377, 1994.
13. Sträter, J., Koretz, K., Günthert A. R., and Möller, P. In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut, 37: 819-825, 1995.
14. Möller, P., Walczak, H., Riedl, S., Sträter, J., and Krammer, P. Paneth cells express high levels of CD95 ligand transcripts. A unique property among gastrointestinal epithelia. Am. J. Pathol., 149: 9-13, 1996.
15. De Maria, R., Biorivant, M., Grazia Cifine, M., Roncaioli, P., Hahne, M., Tschopp, J., Pallone, F., Santoni, A., and Testi, R. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role of the acidic sphingomyelinase pathway in normal immunoregulation. J. Clin. Invest., 97: 316-322, 1996.
16. Sträter, J., Wellisch, I., Riedl, S., Walczak, H., Koretz, K., Tandara, T., Krammer, P. H., and Möller, P. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology, 113: 160-167, 1997.
17. Owen-Schaub, L. B., Radinsky, R., Kruzel E., Berry K., and Yonehara, S. Anti-Fas on nonhematopoetic tumors: levels of Fas/Apo-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res., 54: 1580-1586, 1994.
18. Yonehara, S., Ishii, A., and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med., 169: 1747-1756, 1989.
19. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med., 177: 195-200, 1993.
20. Sträter, J., Wedding, U., Barth, T. F. E., Koretz, K., Elsing, C., and Möller, P. Rapid onset of apoptosis in vitro follows disruption of β1-integrin/matrix interactions in human colon crypt cells. Gastroenterology, 110: 1776-1784, 1996.
21. Gschwendt, M., Fürstenberger, G., Leibersperger, H., Kittstein, W., Lindner, D., Rudolph, C., Barth, H., Kleinschroth, J., Marmé, D., Schächtele, C., and Marks, F. Lack of an effect of novel inhibitors with high specifity for protein kinase C on the action of the phorbolester 12-O-tetradecanoylphorbol-13-acetate on mouse skin in vivo. Carcinogenesis (Lond.), 16: 107-111, 1995.
22. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 39: 271-279, 1991.
23. Whitehead, R. H., Brown, A., and Bhathal, P. S. A method for isolation and culture of human colonic crypts in collagen gels. In Vitro, 23: 436-442, 1987.
24. Hallowes, R. C., Bone, E. J., and Jones, W. A. A new dimension in the culture of human breast. In: K. T. Richards (ed.). Tissue Culture in Medical Research, Vol. 2., pp. 213-220. Oxford, United Kingdom: Pergamon Press, 1980.
25. Koch, N., Moldenhauer, G., Hofmann, W. J., and Möller, P. Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74). J. Immunol., 147: 2643-2651, 1991.
26. Lippincott-Schwartz, J., Yuan, L., Tripper, C., Amherdt, M., Orci, L., and Klausner, R. D. Brefeldin A's effect on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell, 67: 601-616, 1991.
27. Cohen, J. J., and Duke, R. C. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol., 10: 267-293, 1992.
28. Ni, R., Tomita, Y., Matsuda, K., Ichihara, A., Ishimura, K., Ogasawara, J., and Nagata, S. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res., 215: 332-337, 1994.
29. Henne, C., Schwenk, F., Koch, N., and Möller, P. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. Immunology, 84: 177-182, 1995.
30. Borelli, M. J., Stafford, D. M., Rausch, C. M., Ofenstein, J. P., Cosenza, S. C., and Soprano, K. J. Cycloheximide protection against actinomycin D cytotoxicity. J. Cell. Physiol., 153: 507-517, 1992.
31. McConkey, D. J. Signal transduction pathways to apoptosis. Cell Biol., 4: 370-375, 1994.
32. Jacobson, M. D., Brune, J. F., and Raff, M. C. Programmed cell death and BCL-2 protection in the absence of a nucleus. EMBO J., 13: 1899-1910, 1994.
33. Leibovitz, A., Stinson, J. C., McCombs, W., III, McCoy, C. E., Mazur, K. C., and Mabry, N. D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res., 36: 4562-4569, 1976.
34. Nagata, S., and Golstein, P. The Fas death factor. Science (Washington DC), 267: 1449-1456, 1995.
35. Klas, C., Debatin, K-M., Jonker, R. R., and Krammer, P. H. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol., 5: 625-630, 1993.
36. Crispe, I. N. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity, 1: 347-349, 1994.
37. Weller, M., Frei, K., Grosurth, P., Krammer, P. H., Yonekawa, Y., and Fontana, A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation by cytokines. J. Clin. Invest., 94: 954-964, 1994.
38. Deiss, L. P., Feinstein, E., Berissi, H., Cohen, O., and Kimchi, A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ interferon-induced cell death. Genes Dev., 9: 15-30, 1995.
39. Deiss, L. P., Galinka, H., Berissi, H., Cohen, O., and Kimchi, A. Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α. EMBO J., 15: 3861-3870, 1996.
40. Evans, G., Wyllie, A., Gilbert, C., Littlewood, T., Land, H., Brooks, M., Penn, L., and Hancock, D. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 63: 119-132, 1992.
41. Yang, E., and Korsmeyer, S. J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood, 88: 386-401, 1996.
42. 2 in breast carcinoma cells. Oncogene, 10: 2297-2305, 1995.
43. Clément, M-V., and Stamenkovic, I. Superoxide anion is a natural inhibitor of Fas-mediated cell death. EMBO J., 15: 216-225, 1996.
44. Hug, H., Enari, M., and Nagata, S. No requirement of reactive oxygen intermediates in Fas-mediated apoptosis. FEBS Lett., 351: 311-313, 1994.
45. Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishioka, W., Brunner, T., Baier, G., Baier-Bitterlich, G., Byrd, C., Lang, F., Koleshnick, R., Altman, A., and Green, D. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity, 2: 341-351, 1995.
46. Cifone, M. G., De Maria, R., Roncailoni, P., Rippo, M. R., Azuma, M., Lanier, L. L., Santoni, A., and Testi, R. Apoptotic signaling through CD95(Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med., 177: 1547-1552, 1993.
47. Tepper, C. G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y. A., and Seldin, M. F. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA, 92: 8443-8447, 1995.
48. O'Connell, J., O'Sullivan, G. C., Collins, J. K., and Shanahan, F. The Fas counterattack: Fas-mediated T cell killing by colon carcinoma cells expressing Fas ligand. J. Exp. Med., 184: 1075-1082, 1996.